Skip to main content
Industry Update
R WE ready for reimbursement? A round-up of developments in real-world evidence relating to health technology assessment: part 27
- Paul Arora and
- Sreeram V Ramagopalan
e260144
Published Online:14 July 2026
Access in all areas? A round-up of developments in market access and health technology assessment: part 15
- Sreeram V Ramagopalan and
- Annie Jullien Pannelay
e260111
Published Online:1 July 2026
Short Report
Mortality risk estimation for autistic older adults: comparing novel machine-learning derived weights versus standard weights for the Charlson Comorbidity Index
- Madison Blake,
- Melica Nikahd,
- J Madison Hyer,
- Brian W Patterson,
- Bethany J Wolf,
- Lauren Bishop, and
- Brittany N Hand
e260053
Published Online:29 July 2026
Research Article
Lung cancer screening in Lithuania: a cost-effectiveness analysis
- Hilde ten Berge,
- Greta Piazza,
- Dianne Ramaker,
- Xuanqi Pan,
- Titas Bukšnys,
- Saulius Cicėnas,
- Skaidrius Miliauskas,
- Giedre Smailyte,
- Rolandas Zablockis,
- Marius Zemaitis, and
- Edvardas Danila
e260034
Published Online:16 July 2026
Validity of HINT-8 in evaluating health-related quality of life among cervical cancer patients
- Ah-Yeon Lee,
- Soo Hyeon Lee,
- Min-Ju Kim,
- Ji-Eun An,
- Gyeong-U Hong,
- Woo-Jeong Sim,
- Hyunji Lim,
- Tae-Wook Kong,
- Byung Su Kwon,
- Sung Taek Park,
- Kyeong A So,
- Won Moo Lee,
- Jung-Yun Lee,
- Dae Hoon Jeong,
- Min Chul Choi,
- Youn Jin Choi,
- Jae-Kwan Lee,
- Tae-Hwe Heo,
- Kyung-Jin Min, and
- Su-Yeon Yu
e250194
Published Online:24 July 2026
Real-world comparative effectiveness of analogue and human insulin on glycemic control in children and adolescents with Type 1 diabetes in Lebanon using continuous glucose monitoring data
- Sahar Masri,
- Manuel Albela,
- Iza Ciglenecki,
- Philippa Boulle,
- Tania Hachem,
- Sola Bahous,
- David Prieto-Merino, and
- Pablo Perel
e260036
Published Online:16 July 2026
A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfa
- Amy Dymond,
- Will Green,
- Matthew Crabtree,
- Alasdair MacCulloch,
- Neil Johnson,
- Simon Shohet,
- Vera Gielen,
- Sophie Clarke,
- Patrick Deegan, and
- Jordi Diaz-Manera
e250202
Published Online:15 July 2026
Transparency in positive airway pressure therapy trials: an evaluation of reporting quality
- Petra Stazić Kunčić,
- Diana Gujinović,
- Renata Pecotić,
- Zoran Đogaš,
- Ana Marušić, and
- Marija Roguljić
e260058
Published Online:23 July 2026
Effect of dose tapering policy on the prescription of advanced therapy for rheumatoid arthritis: a retrospective analysis of clinical and cost outcomes in Taiwan
- Ko-Jen Li,
- Chao-Hsiun Tang,
- Chia-Li Chang,
- Han-Fang Liao,
- Pei-Jung Yen, and
- Wen-Yi Shau
e260020
Published Online:30 July 2026
Understanding the economic and healthcare burden of metabolic dysfunction-associated steatohepatitis: a real-world claims data analysis from Germany
- Frank Tacke,
- Yestle Kim,
- Jennifer S Haas,
- Melinda J Daumont,
- Christopher Maas,
- John O'Donnell, and
- Jörn M Schattenberg
e260092
Published Online:22 July 2026
Meta-Analysis
Systematic review and network meta-analysis of the efficacy, safety and tolerability of xanomeline plus trospium chloride compared with eight oral antipsychotics for the acute treatment of schizophrenia
- Conor Hickey,
- Matthew F Sidovar,
- Andrea Garcia,
- Ken Kramer,
- Jen-Yu Amy Chang,
- Katrin Kupas,
- Vyshnavi Telukuntla,
- Jake Horgan,
- Haris Jameel,
- Tracy Westley,
- Kristin K Gillard, and
- Andrew J Cutler
e260045
Published Online:30 July 2026